@ShahidNShah
Patient-First Model: High Tech Meets High Touch For Patients With Rare Disorders
Industry experts state that orphan drugs will be a major trend to watch in the years ahead, accounting for almost 40% of the Food and Drug Administration approvals this year. This market has become more competitive in the past few years, increasing the potential for reduced costs and broader patient accessibility. Currently, these products are often expensive because they target specific conditions and cost on average $147,000 or more per year, making commercialization optimization particularly critical for success.
At the same time precision medicine—a disease treatment and prevention approach that takes into account individual variability in genes, environment, and lifestyle for each person—is emerging as a trend for population health management. This approach utilizes advances in new technologies and data to unlock information and better target health care efforts within populations.
Continue reading at hitconsultant.net
Make faster decisions with community advice
- 30 Executives Share Top Healthcare Predictions & Trends To Watch in 2021
- 6 Mental Health & Teletherapy Predictions & Trends to Watch In 2021
- Adoption of Safer Enteral Connections Key to Patient Safety
- Setting The Facts Straight: 3 Common Misconceptions When Applying Automation To The Revenue Cycle
- Simple Algorithms vs. A.I. And What They Mean For Medicine
Next Article
-
Setting The Facts Straight: 3 Common Misconceptions When Applying Automation To The Revenue Cycle
After an extremely difficult year – one where health systems now face losses projected to exceed $323 billion due to COVID-19 and as much as $200 billion in administrative waste as a result of revenue …
Posted Dec 31, 2020 Revenue Cycle Management